← Back to Awards
NIHNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Task 12: Sexually Transmitted Infections Clinical Trials Group: Phase 2 Clinical Trial to Evaluate a Vaccine Candidate for Neisseria Gonorrhoeae
- Institution
- University of Alabama at Birmingham, AL
- Principal investigator
- Edward Hook
- Funding
- $1.0M
- Duration
- 2019–2026
Moonbase score
Still being scored
Abstract
The Sexually Transmitted Infections Clinical Trials Group provides infrastructure to conduct sexually transmitted infections (STIs) related clinical research, including providing clinical sites, trained and experienced personnel, laboratories, protocol development, clinical trial coordination, biological sample collection, storage, scientific leadership, and other aspects related to the conduct of clinical studies.
LOADING MOONBASE SCORE
Questions for University of Alabama at Birmingham
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same institution, same topic, scored first.
- NSF · University of Alabama at Birmingham61
High-Entropy Alloy Superconductors under High Pressures
Yogesh K Vohra · $457K · 2023–2026
- NIH · University of Alabama at Birmingham59
Dihydroxyacetone exposure induces metabolic reprogramming and mitochondrial dysfunction
Natalie Rose Gassman · $306K · 2021–2025
- NIH · University of Alabama at Birmingham49
Distinct Glycophenotypes with Abnormal Signaling Define a Subpopulation of B cells Responsible for Production of Galactose-Deficient IgA1, the Main Autoantigen in IgA Nephropathy
Colin Robert Reily · $448K · 2023–2027